Page last updated: 2024-08-24

triazoles and volasertib

triazoles has been researched along with volasertib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cai, MC; Di, W; Gao, WQ; Gu, Z; Ji, ZL; Jing, Y; Ma, P; Peng, H; Yan, Y; Zhang, M; Zhang, S; Zhang, Z; Zhuang, G1
Burgos, M; Corrales-Sanchez, V; Domingo, B; Esparis-Ogando, A; Galan-Moya, EM; Gomez-Juarez, M; Montero, JC; Nieto-Jimenez, C; Noblejas-Lopez, MDM; OcaƱa, A; Pandiella, A; Picazo-Martinez, MG1

Other Studies

2 other study(ies) available for triazoles and volasertib

ArticleYear
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1.
    Theranostics, 2016, Volume: 6, Issue:2

    Topics: Animals; Antineoplastic Agents; Azepines; Carcinoma; Cell Line, Tumor; Down-Regulation; Female; Forkhead Box Protein M1; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Proteins; Ovarian Neoplasms; Pteridines; Transcription Factors; Triazoles

2016
Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer.
    Cancer letters, 2020, 10-28, Volume: 491

    Topics: Animals; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Humans; Mice; Mice, Inbred BALB C; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proteins; Proto-Oncogene Proteins; Pteridines; Triazoles; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2020